Cancer clinical trials accrual: Missed opportunities to address disparities and missed opportunities to improve outcomes for all

Annals of Surgical Oncology

Volumn 15, Issue 7, 2008, Pages 1818-1819

  Newman, Lisa A ^a   Roff, Nathalie Kim ^b   Weinberg, Armin D ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; BREAST CANCER; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER RISK; CARCINOMA IN SITU; CLINICAL TRIAL; COMORBIDITY; DEMOGRAPHY; DIET; EDITORIAL; ETHNICITY; HUMAN; LIFESTYLE; RACE DIFFERENCE; RECTUM CANCER;

CLINICAL TRIALS AS TOPIC; HEALTH SERVICES RESEARCH; HEALTHCARE DISPARITIES; HUMANS; MINORITY GROUPS; NEOPLASMS; PATIENT SELECTION;

EID: 46149110762     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-9869-2     Document Type: Editorial

References (2)

1. Stewart JH, Bertoni AG, Staten JL, et al. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol 2007; 14:3328-34.
2. Newman LA, Lee CT, Parekh LP, et al. American College of Surgeons Oncology Group (ACOSOG) Special Population Committee. Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee. Cancer 2006; 106:188-95.